Related Guides
Goal and condition context for deciding what to read next.
Compound Profile
Resveratrol carries a Grade B rating — moderate evidence.
Review needed — GI upset Details
Safety
GI upset
Standard caution
Caution level: Standard. No specific caution categories were detected in the source record.
Evidence-based safety
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
Bleeding / anticoagulant risk
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Data provenance recorded for 147 of 147 pairings in this mechanism group.
+135 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Useful signal, but study design, dose, and population still matter.
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Oxidative Stress Modulation · Mitochondrial Support
Research maturity: Established research — main contexts: Anti Inflammatory · Antioxidant
Safety boundary: Safety note available — GI upset
This profile cites 5 human studies.
Confidence estimate based on the design quality and consistency of published clinical trials.
Resveratrol has a moderate evidence rating.
Evaluation of methodological rigor, population reach, and evidence alignment.
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
Filter by study class
Showing 4 of 4 studies.
What the evidence actually shows
This table contains 4 structured sources, including 3 human evidence sources; 0 are human trials.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | A 2026 meta-analysis of 23 randomized trials in 1,005 adults with overweight or obesity found no significant effect of resveratrol on body weight, BMI, fat mass, body-fat percentage, fat-free mass, waist-to-hip ratio, adiponectin, or leptin; waist circumference decreased modestly. | PubMed → |
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | A seven-trial meta-analysis found no significant improvement in ApoB or ApoA-I with resveratrol. This null evidence should remain visible rather than being overshadowed by broader mechanistic or cardiometabolic claims. | PubMed → |
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | A 2025 meta-analysis found no significant overall effect of resveratrol on SIRT1 gene expression, SIRT1 protein expression, or serum SIRT1 levels. Some duration- or tissue-specific subgroup signals did not alter the null overall findings. | PubMed → |
Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | Synthesis of hyperbranched polyethylene amphiphiles by chain walking polymerization in tandem with RAFT polymerization and supramolecular self-assembly vesicles | PubMed → |
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Resveratrol Works
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Source botanicals and comparison guides related to Resveratrol.
Compare side-by-side tradeoffs or verify active marker guidelines.
Sourcing options
Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.
When sourcing Resveratrol, verify the label for:
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Founder & Head Researcher · Oak Ridge, TN · Last reviewed August 2026
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.